NS Investment

NS Investment is a South Korean venture capital firm specializing in biotechnology and healthcare investments. Established in 2015 by Kang Jung-seok, the third-generation owner of the Dong-A Socio Holdings Group, NS Investment operates as an affiliated firm of Dong-A ST, a leading pharmaceutical company in South Korea. The firm focuses on linking Korean investor capital with innovative companies beyond its domestic borders, aiming to connect entrepreneurs and science across continents. NS Investment is composed of pharmaceutical and bio professionals, including those from Dong-A Pharmaceutical, enabling them to discover promising deals, particularly in the United States. They have consistently formed 'Global Bio Investment Associations' jointly with Paratus Investment. The firm's investment activities are primarily overseas, mainly in the United States, where they have consistently formed 'Global Bio Investment Associations' jointly with Paratus Investment. Their portfolio includes investments in companies such as DND Pharmatech, a developer of Alzheimer's treatments; Robotus, a developer of collaborative robots; Genome & Company, a new drug developer; and Vuno, an AI medical device developer. These investments reflect NS Investment's commitment to advancing healthcare and biotechnology through strategic partnerships and funding.